Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.

MLA

Russo, Francesco Paolo, et al. “Hepatitis C Virus Eradication with Direct-Acting Antiviral Improves Insulin Resistance.” Journal of Viral Hepatitis, vol. 27, no. 2, Feb. 2020, pp. 188–94. EBSCOhost, https://doi.org/10.1111/jvh.13215.

APA

Russo, F. P., Zanetto, A., Gambato, M., Bortoluzzi, I., Al Zoairy, R., Franceschet, E., De Marchi, F., Marzi, L., Lynch, E. N., Floreani, A., Farinati, F., Schaefer, B., Burra, P., Zoller, H., & Mega, A. (2020). Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance. Journal of Viral Hepatitis, 27(2), 188–194. https://doi.org/10.1111/jvh.13215

Chicago

Russo, Francesco Paolo, Alberto Zanetto, Martina Gambato, Ilaria Bortoluzzi, Ramona Al Zoairy, Enrica Franceschet, Federica De Marchi, et al. 2020. “Hepatitis C Virus Eradication with Direct-Acting Antiviral Improves Insulin Resistance.” Journal of Viral Hepatitis 27 (2): 188–94. doi:10.1111/jvh.13215.